<DOC>
	<DOCNO>NCT00496028</DOCNO>
	<brief_summary>This study comprise 2 part , dose escalation phase dose expansion phase . The 2 phase part single study describe single protocol . Patients enter dose escalation phase enter expansion phase . All subject must suitable treatment either carboplatin and/or paclitaxel .</brief_summary>
	<brief_title>Phase I Study Patients With Solid Tumours</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Saracatinib</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Life expectancy &gt; 12 week Women define postmenopausal Male female patient locally advanced metastatic cancer suitable treatment carboplatin and/or paclitaxel Inadequate bone marrow reserve Inadequate live function , renal function low haemoglobin Unresolved toxicity anticancer therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Solid tumor</keyword>
	<keyword>locally advanced Metastatic Cancer suitable treatment carboplatin and/or paclitaxel</keyword>
</DOC>